FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Leyser, M
   Marques, F
   Amarante, C
   Elias, MA
   Klein, R
   Nascimento, OJM
AF Leyser, Marcio
   Marques, Fernanda
   Amarante, Claret
   Elias, Marco Aurelio
   Klein, Renata
   Nascimento, Osvaldo J. M.
TI Developmental Outcomes in a Cohort of Infants Born With Congenital ZIKA
   Syndrome
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Meeting Abstract
C1 [Leyser, Marcio] Univ Iowa, Iowa City, IA USA.
   [Marques, Fernanda; Amarante, Claret; Elias, Marco Aurelio; Klein, Renata] SARAH Network Rehabil Hosp, Rio De Janeiro, Brazil.
   [Nascimento, Osvaldo J. M.] Fluminense Fed Univ, Niteroi, RJ, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD FEB-MAR
PY 2020
VL 41
IS 2
MA 79
BP S18
EP S19
PG 2
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA LE6SH
UT WOS:000526852800042
DA 2020-12-14
ER

PT J
AU Leyser, M
   Marques, F
   Teixeira, MC
   Barra, R
   Almeida, A
   Penna, P
   Carvalho, R
   Gonsalves, M
   Nascimento, OJM
AF Leyser, Marcio
   Marques, Fernanda
   Teixeira, Marta Cristina
   Barra, Rafael
   Almeida, Alexandre
   Penna, Patricia
   Carvalho, Ricardo
   Gonsalves, Marcia
   Nascimento, Osvaldo J. M.
TI Clinical and Brain-Related Anatomo-Physiological Findings in a Cohort of
   Infants Born with Congenital ZIKA Syndrome
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Meeting Abstract
C1 [Leyser, Marcio] Univ Iowa, Iowa City, IA USA.
   [Marques, Fernanda; Teixeira, Marta Cristina; Barra, Rafael; Almeida, Alexandre; Penna, Patricia; Carvalho, Ricardo; Gonsalves, Marcia] SARAH Network Rehabil Hosp, Rio De Janeiro, Brazil.
   [Nascimento, Osvaldo J. M.] Fluminense Fed Univ, Niteroi, RJ, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD FEB-MAR
PY 2020
VL 41
IS 2
MA 80
BP S19
EP S19
PG 1
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA LE6SH
UT WOS:000526852800043
DA 2020-12-14
ER

PT J
AU Leyser, M
   Marques, FJP
   Nascimento, OJM
AF Leyser, Marcio
   Marques, Fernanda J. P.
   Nascimento, Osvaldo J. M.
TI A multilevel-based research framework on congenital Zika syndrome
SO PEDIATRIC RESEARCH
LA English
DT Editorial Material
C1 [Leyser, Marcio] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
   [Marques, Fernanda J. P.; Nascimento, Osvaldo J. M.] Fluminense Fed Univ, Antonio Pedro Univ Hosp, Dept Neurol, Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
EM marcio-leyser@uiowa.edu
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Ribeiro BG, 2017, RADIOGRAPHICS, V37, P1840, DOI 10.1148/rg.2017170023
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   2018, CHILDS NERV SYST, V34, P63
   2018, NAT MICROBIOL, V3, P1214
NR 7
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD MAY
PY 2019
VL 85
IS 6
BP 745
EP 746
DI 10.1038/s41390-019-0349-0
PG 2
WC Pediatrics
SC Pediatrics
GA HW0YI
UT WOS:000466408300005
PM 30791041
OA Bronze
DA 2020-12-14
ER

PT J
AU Marques, FJP
   Teixeira, MCS
   Barra, RR
   de Lima, FM
   Dias, BLS
   Pupe, C
   Nascimento, OJM
   Leyser, M
AF Marques, Fernanda J. P.
   Teixeira, Marta C. S.
   Barra, Rafael R.
   de Lima, Fernanda M.
   Scofano Dias, Bruno L.
   Pupe, Camila
   Nascimento, Osvaldo J. M.
   Leyser, Marcio
TI Children Born With Congenital Zika Syndrome Display Atypical Gross Motor
   Development and a Higher Risk for Cerebral Palsy
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE congenital Zika syndrome; cerebral palsy; gross motor development
ID VIRUS-INFECTION; CHILDHOOD; SPECTRUM
AB Importance: Congenital Zika syndrome virus infection is said to interfere in children's development. Objective: evaluate gross motor trajectories and the frequency of cerebral palsy in children with congenital Zika syndrome. Design: Cohort study applying the Alberta Infant Motor Scale (AIMS) and the Bayley III Scales in infants from 6 to 18 months of age. Setting: The SARAH network, Rio de Janeiro. Participants: Thirty-nine infants whose diagnoses were established through clinical history, serology tests, and neuroimaging findings. Main outcomes and measures: Congenital Zika syndrome is associated with severe motor delays and is a risk factor to the diagnosis of cerebral palsy. Results: The Alberta Infant Motor Scale mean raw score at 6 months was 9.74 (SD 4.80) or equivalent to 2 to 3 months of motor developmental age. At the age of 12 months, 14.13 (SD 11.90), corresponding to 3 to 4 months of motor development age; the Bayley III Scales results correlated to the Alberta Infant Motor Scale (P < .001) at this age. At 18 months, 15.77 (SD 13.80) or a motor development equivalent to 4 to 5 months of age. Thirty-five of 39 children (89.7%) met criteria for the diagnosis of cerebral palsy. Conclusions and relevance: Gross motor development marginally progresses from 6 to 18 months of age. These individuals also displayed a high frequency of cerebral palsy.
C1 [Marques, Fernanda J. P.; Teixeira, Marta C. S.; Barra, Rafael R.; de Lima, Fernanda M.; Scofano Dias, Bruno L.] SARAH Network Rehabil Hosp, Av Canal Arroio Pavuna S-N, BR-22261001 Rio De Janeiro, Brazil.
   [Marques, Fernanda J. P.; Pupe, Camila; Nascimento, Osvaldo J. M.] Fed Fluminense Univ, Niteroi, RJ, Brazil.
   [Leyser, Marcio] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA USA.
RP Marques, FJP (corresponding author), SARAH Network Rehabil Hosp, Av Canal Arroio Pavuna S-N, BR-22261001 Rio De Janeiro, Brazil.
EM fernandajpmarques@gmail.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Braga LW, 2005, CHILD TRAUMATIC BRAI
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jacobsson B, 2004, BEST PRACT RES CL OB, V18, P425, DOI 10.1016/j.bpobgyn.2004.02.011
   Leyser M, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0048
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   PIPER MC, 1992, CAN J PUBLIC HEALTH, V83, pS46
   Ribeiro BG, 2017, RADIOGRAPHICS, V37, P1840, DOI 10.1148/rg.2017170023
   Rintala P, 2013, PERCEPT MOTOR SKILL, V116, P294, DOI 10.2466/25.10.PMS.116.1.294-303
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Silva NDSH, 2011, REV BRAS CRESC DESEN, V21, P85, DOI DOI 10.7322/JHGD.19998
   UNICEF, EARL CHILDH DEV KEY
   Valentini Nadia Cristina, 2011, Rev. paul. pediatr., V29, P231, DOI 10.1590/S0103-05822011000200015
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 24
TC 11
Z9 11
U1 0
U2 16
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD FEB
PY 2019
VL 34
IS 2
BP 81
EP 85
DI 10.1177/0883073818811234
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA HG4JF
UT WOS:000454940800004
PM 30421639
DA 2020-12-14
ER

PT J
AU Leyser, M
AF Leyser, Marcio
TI Child Neurology: A Fragile Future
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Editorial Material
C1 [Leyser, Marcio] Univ Iowa, Ctr Disabil & Dev, 100 Hawkins Dr, Iowa City, IA 52242 USA.
RP Leyser, M (corresponding author), Univ Iowa, Ctr Disabil & Dev, 100 Hawkins Dr, Iowa City, IA 52242 USA.
EM marcio-leyser@uiowa.edu
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Roberts M, 2012, AM J PSYCHIAT, V169, P1141, DOI 10.1176/appi.ajp.2012.12070916
NR 1
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAY
PY 2018
VL 33
IS 6
BP 432
EP 432
DI 10.1177/0883073818760920
PG 1
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GD1AJ
UT WOS:000430232100010
PM 29514534
DA 2020-12-14
ER

PT J
AU Leyser, M
   Nascimento, OJM
AF Leyser, Marcio
   Nascimento, Osvaldo J. M.
TI Congenital Zika Virus Infection: Beyond Neonatal Microcephaly
SO JAMA NEUROLOGY
LA English
DT Letter
C1 [Leyser, Marcio; Nascimento, Osvaldo J. M.] Fed Fluminense Univ, Antonio Pedro Univ Hosp, Niteroi, RJ, Brazil.
RP Nascimento, OJM (corresponding author), Fed Fluminense Univ, Antonio Pedro Univ Hosp, NeuroUPC Clin Res Unit Neurol & Neurosci, Niteroi, RJ, Brazil.
EM osvaldo_nascimento@hotmail.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
NR 4
TC 3
Z9 3
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD MAY
PY 2017
VL 74
IS 5
BP 610
EP 610
DI 10.1001/jamaneurol.2017.0048
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA EU2EE
UT WOS:000400838900027
PM 28319237
DA 2020-12-14
ER

PT J
AU Leyser, M
   Fernandes, A
   Passos, P
   Pupe, C
   Matta, APC
   Vasconcelos, MM
   Nascimento, OJM
AF Leyser, Marcio
   Fernandes, Alexandre
   Passos, Pamela
   Pupe, Camila
   Matta, Andre P. C.
   Vasconcelos, Marcio Moacyr
   Nascimento, Osvaldo J. M.
TI Microcephaly and arthrogryposis multiplex congenita: The full-blown CNS
   spectrum in newborns with ZIKV infection
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
ID VIRUS
AB The recent alarming statements concerning the newborn ZIKV-induced microcephaly epidemics in the Northeast of Brazil, released by the Brazilian Ministry of Health, as well as important international health agencies, such as the World Health Organization and the Pan American Health Organization, raised many "why and how" questions so far, that will hopefully be scientifically answered, as more researches in that regard come up in the long term.
   In this paper, we describe another potentially ZIKV-induced central nervous system and musculoskeletal disorder that has accompanied microcephaly in these children: atrhogryposis multiplex congenita.
   The goal is to bring up some hypotheses for possible underlying molecular mechanisms based on published data taken from animal models, such as ovine and cattle, which once infected by other types of arboviroses and viruses that also belong to the Flaviviridae family, presented, too, with the full-blown CNS spectrum of malformations at birth. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Leyser, Marcio; Fernandes, Alexandre; Passos, Pamela; Pupe, Camila; Matta, Andre P. C.; Vasconcelos, Marcio Moacyr; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, BR-24033900 Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), Univ Fed Fluminense, Antonio Pedro Univ Hosp, BR-24033900 Niteroi, RJ, Brazil.
EM marcioley@icloud.com
RI Leyser, Marcio/Z-4422-2019; Fernandes, Alexandre R/K-3341-2016
OI Leyser, Marcio/0000-0002-2929-8416; Fernandes,
   Alexandre/0000-0001-6253-265X
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kul O, 2008, VET PATHOL, V45, P191, DOI 10.1354/vp.45-2-191
   Mlakar J., 2016, NEW ENGL J MED
   Moller-Madsen B, 2015, J CHILD ORTHOP, V9, P425, DOI 10.1007/s11832-015-0688-2
   Peperkamp NH, 2015, VET PATHOL, V52, P1057, DOI 10.1177/0300985814560231
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tetro J.A., 2016, MICROBES INFECT, P1
NR 13
TC 7
Z9 7
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2017
VL 372
BP 73
EP 74
DI 10.1016/j.jns.2016.11.030
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EJ1WZ
UT WOS:000393002500016
PM 28017252
DA 2020-12-14
ER

PT J
AU Leyser, M
   de Camargo, OK
   Matta, APC
   Vasconcelos, MM
   Nascimento, OJM
AF Leyser, Marcio
   de Camargo, Olaf Kraus
   Matta, Andre P. C.
   Vasconcelos, Marcio Moacyr
   Nascimento, Osvaldo J. M.
TI The International Classification of Functioning framework in
   Zika-related disabilities
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Letter
ID CHILDHOOD
C1 [Leyser, Marcio; Matta, Andre P. C.; Vasconcelos, Marcio Moacyr; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Niteroi, RJ, Brazil.
   [de Camargo, Olaf Kraus] McMaster Univ, Hamilton, ON, Canada.
RP Leyser, M (corresponding author), Antonio Pedro Univ Hosp, NeuroUPC, R Marques Parana,303-5th Floor Ctr, BR-24033900 Niteroi, RJ, Brazil.
EM marcioley@hotmail.com
RI de Camargo, Olaf Kraus/G-8419-2011; Leyser, Marcio/Z-4422-2019
OI de Camargo, Olaf Kraus/0000-0002-7927-7189; Leyser,
   Marcio/0000-0002-2929-8416
CR DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Kraus de Camargo O., 2016, BRAZ J MED HUM HLTH, V4, P29
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Rosenbaum P, 2012, CHILD CARE HLTH DEV, V38, P457, DOI 10.1111/j.1365-2214.2011.01338.x
   Rosenbaum P, 2009, NEUROPEDIATRICS, V40, P56, DOI 10.1055/s-0029-1234104
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 7
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV
PY 2016
VL 20
IS 6
BP 946
EP 947
DI 10.1016/j.ejpn.2016.08.001
PG 2
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA EA1BC
UT WOS:000386322300021
PM 27558313
DA 2020-12-14
ER

PT J
AU Leyser, M
   Dias, BL
   Coelho, AL
   Vasconcelos, M
   Nascimento, OJM
AF Leyser, Marcio
   Dias, Bruno Leonardo
   Coelho, Ana Luiza
   Vasconcelos, Marcio
   Nascimento, Osvaldo J. M.
TI 12p deletion spectrum syndrome: a new case report reinforces the
   evidence regarding the potential relationship to autism spectrum
   disorder and related developmental impairments
SO MOLECULAR CYTOGENETICS
LA English
DT Article
DE Autism spectrum disorder; 12p13.2 microdeletion; 12p microdeletion
   spectrum; Developmental delay
ID MB TERMINAL DELETION; SHORT ARM; INTERSTITIAL DELETION; CHROMOSOME 12P;
   SUBTELOMERIC DELETION; MENTAL-RETARDATION; RECEPTOR; PATIENT;
   ABNORMALITIES; RESOLUTION
AB Background: Autism Spectrum Disorders (ASD) now encompass a broad heterogeneous group of people who present in the early developmental years with a wide range of social and communication deficits, which are typically also associated with complex repetitive behaviors and circumscribed interests.
   The target goal is to heighten readers' perception into the trend to personalize the distinct autistic and related developmental conditions encompassing the 12p region.
   Case Presentation: This is a case-report of a 4-year-old male who presented the core signs of ASD, which were thought to be related to a rare 12p13.2 deletion. We further reviewed the literature in order to outline the related developmental conditions in the 12p region.
   Aside from this patient reported here, we found an additional number of 43 cases described in the medical literature since 1974, that have been related to deletions in the 12p region. However, to the best of our knowledge, none of the previous had been specifically linked to the 12p13.2 band.
   Conclusions: The 12p deletion spectrum is rarely described as part of the selective genotypes thought to be related to ASD. Even inside of a small piece of the puzzle, there might be ample variation in the behavioral and clinical phenotypes of children and adults presenting with this particular genetic profile.
   In that regard, the particular 12p13.2 distal deletion presentation is one of the possible genotypes encompassed by the "12p deletion spectrum syndrome", that might be potentially connected to the diagnosis of ASD and related developmental disorders.
C1 [Leyser, Marcio; Dias, Bruno Leonardo; Coelho, Ana Luiza] Hosp SARAH Int Ctr Neurorehabil & Neurosci, SARAH Network Neurorehabil, Ave Abelardo Bueno 1500, BR-22775040 Rio De Janeiro, RJ, Brazil.
   [Vasconcelos, Marcio; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), Hosp SARAH Int Ctr Neurorehabil & Neurosci, SARAH Network Neurorehabil, Ave Abelardo Bueno 1500, BR-22775040 Rio De Janeiro, RJ, Brazil.
EM marcioleyser@me.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Abdelmoity AT, 2011, EUR J MED GENET, V54, P198, DOI 10.1016/j.ejmg.2010.11.010
   Anagnostou E, 2014, CAN MED ASSOC J, V186, P509, DOI 10.1503/cmaj.121756
   Bahring S, 1997, AM J HUM GENET, V60, P732
   Baker E, 2002, CLIN GENET, V61, P198, DOI 10.1034/j.1399-0004.2002.610305.x
   BARONCINI A, 1990, AM J MED GENET, V36, P358, DOI 10.1002/ajmg.1320360324
   Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204
   Billeke Pablo, 2013, Front Psychiatry, V4, P4, DOI 10.3389/fpsyt.2013.00004
   BOILLYDARTIGALONGUE B, 1985, ANN GENET-PARIS, V28, P55
   Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620
   Butler MG, 2015, INT J MOL SCI, V16, P6464, DOI 10.3390/ijms16036464
   Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102
   Chang J, 2015, NAT NEUROSCI, V18, P191, DOI 10.1038/nn.3907
   Colonna M, 2000, EUR J IMMUNOL, V30, P697
   de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524
   Dimassi S, 2013, AM J MED GENET A, V161, P2564, DOI 10.1002/ajmg.a.36079
   Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677
   FRYNS JP, 1990, ANN GENET-PARIS, V33, P43
   Glaser B, 2003, AM J MED GENET A, V116A, P66, DOI 10.1002/ajmg.a.10878
   Goldani AAS, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00100
   Hansen SN, 2014, INT J EPIDEMIOL, V43, P1988, DOI 10.1093/ije/dyu213
   Hoppe A, 2014, META GENE, V2, P72, DOI 10.1016/j.mgene.2013.10.014
   KIVLIN JD, 1985, AM J MED GENET, V22, P769, DOI 10.1002/ajmg.1320220412
   Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1
   Landgraf MN, 2013, EUR J PAEDIATR NEURO, V17, P437, DOI 10.1016/j.ejpn.2013.03.008
   Liu CC, 2014, NEURON, V84, P63, DOI 10.1016/j.neuron.2014.08.048
   Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106
   Lord C, 2015, AM J MED GENET C, V169, P198, DOI 10.1002/ajmg.c.31440
   Lu HY, 2009, AM J MED GENET A, V149A, P2321, DOI 10.1002/ajmg.a.33030
   MacDonald AH, 2010, AM J MED GENET A, V152A, P1561, DOI 10.1002/ajmg.a.33401
   MAGENIS E, 1981, AM J MED GENET, V9, P95, DOI 10.1002/ajmg.1320090203
   MAGNELLI NC, 1975, J MED GENET, V12, P105, DOI 10.1136/jmg.12.1.105
   MALPUECH G, 1975, LYON MED, V233, P275
   Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200
   MAYEDA K, 1974, AM J HUM GENET, V26, P59
   Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X
   Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003
   NAGAI T, 1995, AM J MED GENET, V55, P16, DOI 10.1002/ajmg.1320550106
   O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835
   ORYE E, 1975, HUMANGENETIK, V28, P335
   Rogers TD, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00015
   ROMAIN DR, 1987, J MED GENET, V24, P434, DOI 10.1136/jmg.24.7.434
   Rooryck C, 2009, EUR J MED GENET, V52, P446, DOI 10.1016/j.ejmg.2009.08.005
   SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436
   Silva IMW, 2014, GENE, V542, P83, DOI 10.1016/j.gene.2014.02.058
   Soysal Y, 2011, AM J MED GENET A, V155A, P1745, DOI 10.1002/ajmg.a.34101
   Stumm M, 2007, PRENATAL DIAG, V27, P475, DOI 10.1002/pd.1703
   Swanwick CC, 2011, AUTISM SPECTRUM DISO, P65
   Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028
   Tarabeux J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.52
   TENCONI R, 1975, ANN GENET-PARIS, V18, P95
   Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767
   Thevenon J, 2013, EUR J HUM GENET, V21, P82, DOI 10.1038/ejhg.2012.116
   Tsang TW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2542
   Vargas H, 2012, EUR J MED GENET, V55, P573, DOI 10.1016/j.ejmg.2012.04.012
   Velinov M, 2008, CNS SPECTRUMS, V13, P515, DOI 10.1017/S1092852900016758
   Volkmar F, 2014, J AM ACAD CHILD PSY, V53, P237, DOI 10.1016/j.jaac.2013.10.013
   Wiemels JL, 2008, CANCER RES, V68, P9935, DOI 10.1158/0008-5472.CAN-08-2139
NR 57
TC 3
Z9 4
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1755-8166
J9 MOL CYTOGENET
JI Mol. Cytogenet.
PD OCT 4
PY 2016
VL 9
AR 75
DI 10.1186/s13039-016-0278-0
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA DX7YD
UT WOS:000384604400001
PM 27708715
OA DOAJ Gold, Green Published
DA 2020-12-14
ER

PT J
AU Leyser, M
   Gonsalvez, MDD
   Vianna, PED
   Fernandes, PA
   Carvalho, RS
   Vasconcelos, MM
   Nascimento, OJM
AF Leyser, Marcio
   Diniz Gonsalvez, Marcia de Castro
   de Souza Vianna, Pedro Erthal
   Fernandes, Paulo Andre
   Carvalho, Ricardo Silva
   Vasconcelos, Marcio Moacyr
   Nascimento, Osvaldo J. M.
TI Scrutinizing brain magnetic resonance imaging patterns in Angelman
   syndrome
SO NEUROLOGY INDIA
LA English
DT Article
DE Angelman syndrome; magnetic resonance imaging; periventricular
   leukomalacia; psychomotor disorders
ID HAPPY PUPPET SYNDROME; CRITERIA; CHILDREN
AB Background: Global developmental delay, lack of speech, and severe epilepsy are the characteristic hallmarks of Angelman syndrome (AS). The purpose of this study was to explore the utility of brain magnetic resonance imaging (MRI) as an ancillary tool for the diagnosis of AS.
   Material and Methods: Brain MRI images of nine laboratory-confirmed patients with AS from a neurorehabilitation center in Rio de Janeiro were reviewed. Each MRI was assessed by a set of two experienced neuroradiologists following a predefined protocol.
   Results: The main neuroimaging findings revealed in our study were: Thinning of the corpus callosum in five patients; enlargement of lateral ventricles in four patients; and, cerebral atrophy with frontal and temporal predominance in one patient. All patients presented with an increased signal intensity in T2-weighted images and fluid-attenuated inversion recovery (FLAIR) sequences.
   Conclusion: The lack of specific changes in the brain MRI of children with AS observed in this case series rendered brain MRI a less helpful complementary test. Thus, a definitive diagnosis of AS could only be established on molecular biology that was undertaken based on the clinical suspicion of AS.
C1 [Leyser, Marcio] SARAH Network Rehabil Hosp, SARAH Int Ctr Neurorehabil & Neurosci, Dept Dev Pediat, Brasilia, DF, Brazil.
   [Diniz Gonsalvez, Marcia de Castro; de Souza Vianna, Pedro Erthal; Fernandes, Paulo Andre; Carvalho, Ricardo Silva] SARAH Network Rehabil Hosp, SARAH Int Ctr Neurorehabil & Neurosci, Dept Neuroradiol, Brasilia, DF, Brazil.
   [Vasconcelos, Marcio Moacyr] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Child Neurol, BR-24220000 Niteroi, RJ, Brazil.
   [Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Neurol, BR-24220000 Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), Ave Arroio Pavuna S-N, BR-22775020 Rio De Janeiro, RJ, Brazil.
EM marcioley@me.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681
   Barkovich AJ, 2012, PEDIAT NEUROIMAGING
   Buoni S, 1999, BRAIN DEV-JPN, V21, P296, DOI 10.1016/S0387-7604(99)00007-8
   Castro-Gago M, 2010, EUR J PAEDIATR NEURO, V14, P292, DOI 10.1016/j.ejpn.2009.07.007
   Chamberlain SJ, 2010, J NEUROSCI, V30, P9958, DOI 10.1523/JNEUROSCI.1728-10.2010
   CLAYTONSMITH J, 1992, ARCH DIS CHILD, V67, P889, DOI 10.1136/adc.67.7.889
   Dan B, 2009, EUR J PAEDIATR NEURO, V13, P269, DOI 10.1016/j.ejpn.2008.08.005
   DORRIES A, 1988, EUR J PEDIATR, V148, P270, DOI 10.1007/BF00441419
   Guerrini Renzo, 2003, Paediatr Drugs, V5, P647, DOI 10.2165/00148581-200305100-00001
   Harting I, 2009, EUR J PAEDIATR NEURO, V13, P271, DOI 10.1016/j.ejpn.2008.04.005
   INCORPORA G, 1994, AM J MED GENET, V52, P246, DOI 10.1002/ajmg.1320520229
   LEONARD CM, 1993, AM J MED GENET, V46, P26, DOI 10.1002/ajmg.1320460107
   Leyser M, 2014, NEUROL SCI, V35, P701, DOI 10.1007/s10072-013-1586-3
   Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001
   Paprocka J, 2007, NEUROLOGIST, V13, P305, DOI 10.1097/01.nrl.0000253067.32759.aa
   Peters SU, 2011, DEV MED CHILD NEUROL, V53, P361, DOI 10.1111/j.1469-8749.2010.03838.x
   Philpot BD, 2011, J NEURODEV DISORD, V3, P50, DOI 10.1007/s11689-010-9066-z
   Scheiffele P, 2010, NATURE, V468, P907, DOI 10.1038/468907a
   Tiwari VN, 2012, NEUROIMAGE, V59, P349, DOI 10.1016/j.neuroimage.2011.07.067
   Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074
   WILLIAMS CA, 1982, AM J MED GENET, V11, P453, DOI 10.1002/ajmg.1320110411
   Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014
   Wilson BJ, 2011, PEDIATR NEUROL, V44, P350, DOI 10.1016/j.pediatrneurol.2010.12.002
NR 23
TC 1
Z9 1
U1 0
U2 5
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD MAR-APR
PY 2016
VL 64
IS 2
BP 228
EP 232
DI 10.4103/0028-3886.177615
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA DG6DN
UT WOS:000372172500007
PM 26954797
DA 2020-12-14
ER

PT J
AU Leyser, M
   Penna, PS
   de Almeida, AC
   Vasconcelos, MM
   Nascimento, OJM
AF Leyser, Marcio
   Penna, Patricia Sola
   de Almeida, Alexandre Cardozo
   Vasconcelos, Marcio Moacyr
   Nascimento, Osvaldo J. M.
TI Revisiting epilepsy and the electroencephalogram patterns in Angelman
   syndrome
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Angelman syndrome; Neurodevelopment; Epilepsy; EEG
ID EEG; DIAGNOSIS; EVOLUTION; SEIZURES; DELETION
AB Angelman syndrome is a neurogenetic disorder that severely affects global neurodevelopment due to modifications in the structure or functioning of UBE3A gene. Its prevalence ranges from 1: 10,000 to 1:40,000. There are four main genetic types of AS transmission. A maternal deletion in 15q11.2-q13 is the most common type. There are three well-established electroencephalogram (EEG) patterns used as an ancillary tool for AS diagnosis. The main objectives are to scrutinize the EEG patterns in Angelman syndrome, their correlation to different types of seizures and to review the role of the EEG as an ancillary screening tool in the diagnosis of clinically suspected patients. Forty-three patients' charts and their previously recorded EEGs were reviewed. A set of 34 patients with deletion type, paternal uniparental disomy type and imprint defect type AS were enrolled. AS diagnosis was confirmed either by fluorescent in situ hybridization test or Methylation Specific-Multiplex Ligation Probe Amplification test. Sequencing of UBE3A was not available. Frequencies and Chi-square tests were used for statistic analysis. Pattern I type EEG was observed in 22 (64.7 %) individuals. Pattern II accounted for 6 (17.6 %); Pattern III was evident in 11 (32.4 %). The three distinguished EEG patterns, more frequently Pattern I, when observed in the appropriate clinical setting, may heighten the index of suspicion for selecting patients who will need a molecular biology test to confirm the diagnosis of AS.
C1 [Leyser, Marcio; Penna, Patricia Sola; de Almeida, Alexandre Cardozo] SARAH Network Neurorehabil Hosp, SARAH Int Ctr Neurorehabil & Neurosci, BR-22775040 Rio De Janeiro, RJ, Brazil.
   [Vasconcelos, Marcio Moacyr; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), SARAH Network Neurorehabil Hosp, SARAH Int Ctr Neurorehabil & Neurosci, Ave Abelardo Bueno 1500, BR-22775040 Rio De Janeiro, RJ, Brazil.
EM marcioley@hotmail.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681
   BOWER BD, 1967, ARCH DIS CHILD, V42, P298, DOI 10.1136/adc.42.223.298
   BOYD SG, 1988, EUR J PEDIATR, V147, P508, DOI 10.1007/BF00441976
   BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395
   Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273
   Buoni S, 1999, BRAIN DEV-JPN, V21, P296, DOI 10.1016/S0387-7604(99)00007-8
   Butler MG, 2009, J ASSIST REPROD GEN, V26, P477, DOI 10.1007/s10815-009-9353-3
   Chamberlain SJ, 2010, J NEUROSCI, V30, P9958, DOI 10.1523/JNEUROSCI.1728-10.2010
   Dan B, 2003, NEUROPEDIATRICS, V34, P169
   Fiumara A, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-31
   Korff CM, 2005, J CLIN NEUROPHYSIOL, V22, P238, DOI 10.1097/01.WNP.0000167930.90824.0F
   Laan LAEM, 2005, BRAIN DEV-JPN, V27, P80, DOI 10.1016/j.braindev.2003.09.013
   Laan LAEM, 1999, CLIN NEUROL NEUROSUR, V101, P161, DOI 10.1016/S0303-8467(99)00030-X
   Laan LAEM, 1997, EPILEPSIA, V38, P195, DOI 10.1111/j.1528-1157.1997.tb01097.x
   Munoz-Cabello B, 2008, REV NEUROLOGIA, V47, P113, DOI 10.33588/rn.4703.2007524
   Pelc K, 2008, SEIZURE-EUR J EPILEP, V17, P211, DOI 10.1016/j.seizure.2007.08.004
   PETERSEN MB, 1995, AM J MED GENET, V60, P261, DOI 10.1002/ajmg.1320600317
   Uemura N, 2005, BRAIN DEV-JPN, V27, P383, DOI 10.1016/j.braindev.2004.01.009
   Valente KD, 2006, ARCH NEUROL-CHICAGO, V63, P122, DOI 10.1001/archneur.63.1.122
   Valente KD, 2005, EPILEPSY RES, V67, P163, DOI 10.1016/j.eplepsyres.2005.09.003
   Valente KD, 2003, EPILEPSIA, V44, P1051, DOI 10.1046/j.1528-1157.2003.66502.x
   Vendrame M, 2012, EPILEPSY BEHAV, V23, P261, DOI 10.1016/j.yebeh.2011.11.027
   Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074
   Yum MS, 2013, BRAIN DEV-JPN, V35, P245, DOI 10.1016/j.braindev.2012.04.006
NR 24
TC 12
Z9 14
U1 0
U2 8
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD MAY
PY 2014
VL 35
IS 5
BP 701
EP 705
DI 10.1007/s10072-013-1586-3
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AI4BJ
UT WOS:000336810100009
PM 24395242
DA 2020-12-14
ER

PT J
AU Leyser, M
   Marques, FJP
   Elias, MAC
   Gonsalves, MCD
   da Silva, OS
   Carvalho, RS
   Silva, CCE
   de Vasconcelos, MM
   Nascimento, OJM
AF Leyser, Marcio
   Marques, Fernanda J. P.
   Elias, Marco Aurelio C.
   Diniz Gonsalves, Marcia C.
   da Silva, Odilon Soares, Jr.
   Carvalho, Ricardo S.
   Costa e Silva, Cynthia
   de Vasconcelos, Marcio Moacyr
   Nascimento, Osvaldo J. M.
TI Classic manifestations of Duchenne dystrophy in a young female patient:
   A case report
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE Duchenne; Becker; Muscular dystrophy; Female
ID BECKER MUSCULAR-DYSTROPHY; MUTATIONS; CARRIERS; GENE; MOSAICISM
AB Duchenne and Becker muscular dystrophies (DMD/DMB) are neuromuscular diseases linked to chromosome X and affect mainly male individuals. Duchenne muscular dystrophy is the most severe form of the disease, leading to a decreased patient survival compared with individuals with Becker type and female carriers of the mutated gene. In this paper we present the case of a female adolescent whose clinical picture and disease course closely resembled male individuals. (C) 2012 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [de Vasconcelos, Marcio Moacyr; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, BR-24220000 Niteroi, RJ, Brazil.
RP Leyser, M (corresponding author), Ave Abelardo Bueno 1500, BR-22775040 Rio De Janeiro, RJ, Brazil.
EM marcioley@hotmail.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553
   Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6
   D'Angelo MG, 2006, MUSCLE NERVE, V34, P16, DOI 10.1002/mus.20535
   Fujii K, 2009, AM J MED GENET A, V149A, P1052, DOI 10.1002/ajmg.a.32808
   Giliberto F, 2003, J BIOCHEM MOL BIOL, V36, P179
   Helderman-van den Enden ATJM, 2010, NEUROMUSCULAR DISORD, V20, P251, DOI 10.1016/j.nmd.2010.01.013
   Hoogerwaard EM, 1999, LANCET, V353, P2116, DOI 10.1016/S0140-6736(98)10028-4
   Katayama Y, 2006, HUM GENET, V119, P516, DOI 10.1007/s00439-006-0159-4
   Medical Research Council, 1981, 45 MED RES COUNC
   Nolan MA, 2003, NEUROMUSCULAR DISORD, V13, P129, DOI 10.1016/S0960-8966(02)00197-9
   Ou ZH, 2010, TOHOKU J EXP MED, V222, P149, DOI 10.1620/tjem.222.149
   Seemann N, 2010, BRAIN PATHOL, V20, P255, DOI 10.1111/j.1750-3639.2009.00344.x
   Soltanzadeh P, 2010, NEUROMUSCULAR DISORD, V20, P499, DOI 10.1016/j.nmd.2010.05.010
   Steffensen B, 2001, Physiother Res Int, V6, P119, DOI 10.1002/pri.221
   van Essen AJ, 2003, AM J MED GENET A, V118A, P296, DOI 10.1002/ajmg.a.10056
NR 16
TC 1
Z9 2
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD MAR
PY 2013
VL 17
IS 2
BP 212
EP 218
DI 10.1016/j.ejpn.2012.08.002
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 106TF
UT WOS:000316166900015
PM 22959238
DA 2020-12-14
ER

PT J
AU Matta, APD
   Chiacchio, SVB
   Leyser, M
AF da Cunha Matta, Andre Palma
   Bonacorsi Chiacchio, Soraya Vilani
   Leyser, Marcio
TI Possible etiologies of West syndrome: evaluation of 95 patients
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE West syndrome; epilepsy; etiology
ID INFANTILE SPASMS; VIGABATRIN
AB Objective: To describe the etiologies of West syndrome (WS) among children followed in a rehabilitation center. Method., Retrospective study with emphasis in the following items: gender, age at the diagnosis of WS and its etiology. The etiologies were divided into three categories: symptomatic, cryptogenic and idiopathic. Symptomatic cases were classified as follows: pre, post and perinatal. Results: Ninety-five patients were included. Fifty-nine were boys (62%). Mean age at the diagnosis was 4.9 ( +/- 5.0) months. There were 25 cryptogenic (26.3%), one idiopathic (1.1%) and 69 (72.6%) symptomatic cases, most of them of perinatal origin. Conclusion: Our findings are in agreement with the literature. In the future, as our knowledge in the field of WS and its diagnostic methods increase, there will be a small number of cryptogenic and idiopathic cases.
C1 Rede Sarah Hosp Reabilitacao, Ctr Reabilitacao Infantil Evandro Carlos Andrade, Rio De Janeiro, Brazil.
RP Matta, APD (corresponding author), Rua Antonio Callado 175-106, BR-22793084 Rio De Janeiro, Brazil.
EM andrepcmatta@sarah.br
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Antoniuk SA, 2000, ARQ NEURO-PSIQUIAT, V58, P683, DOI 10.1590/S0004-282X2000000400014
   Campistol J, 2003, REV NEUROLOGIA, V37, P345, DOI 10.33588/rn.3704.2003181
   Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x
   Mackay MT, 2004, NEUROLOGY, V62, P1668, DOI 10.1212/01.WNL.0000127773.72699.C8
   Matta APC, 2006, ARQ NEURO-PSIQUIAT, V64, P181, DOI 10.1590/S0004-282X2006000200002
   Moraes MHP, 2005, ARQ NEURO-PSIQUIAT, V63, P469, DOI 10.1590/S0004-282X2005000300019
   Ohtsuka Y, 2000, PEDIATR NEUROL, V23, P202, DOI 10.1016/S0887-8994(00)00185-5
   Riikonen R, 2005, CURR OPIN NEUROL, V18, P91, DOI 10.1097/01.wco.0000162847.91531.9c
   Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7
   West WJ, 1841, LANCET, V35, P724, DOI [10.1016/S0140-6736(00)40184-4, DOI 10.1016/S0140-6736(00)40184-4]
NR 10
TC 3
Z9 3
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2007
VL 65
IS 3A
BP 659
EP 662
DI 10.1590/S0004-282X2007000400022
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 210KA
UT WOS:000249453900022
PM 17876410
OA DOAJ Gold
DA 2020-12-14
ER

EF